APA (7th ed.) Citation

G, M., F, M., N, T., H, Y., IG, G., JJ, R., . . . S, C. (2023). Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS -mutated chronic myelomonocytic leukemia. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2023.04.07.535928

Chicago Style (17th ed.) Citation

G, Montalban-Bravo, et al. "Targeting MCL1-driven Anti-apoptotic Pathways to Overcome Hypomethylating Agent Resistance in RAS -mutated Chronic Myelomonocytic Leukemia." BioRxiv : The Preprint Server for Biology 2023. https://doi.org/10.1101/2023.04.07.535928.

MLA (9th ed.) Citation

G, Montalban-Bravo, et al. "Targeting MCL1-driven Anti-apoptotic Pathways to Overcome Hypomethylating Agent Resistance in RAS -mutated Chronic Myelomonocytic Leukemia." BioRxiv : The Preprint Server for Biology, 2023, https://doi.org/10.1101/2023.04.07.535928.